Discovering “dozens” of unknown compounds in cannabis testing samples is a growing occurrence at labs across regulated markets.
Recently, ACT LAB’s Chief Scientific Officer, Dr. Robert (Bob) Miller, was featured in an article by MJBiz discussing the breakdown between the science of testing and the regulations of testing cannabis and hemp-derived products.
Dr. Miller emphasized that the identification of these unknown compounds is crucial for understanding the full profile of cannabis products and ensuring consumer safety. ACT LAB is proud to be at the forefront of cannabis and hemp testing nationwide.
Read the full article to learn more about these groundbreaking findings and the importance of robust testing protocols.